FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

FY24 Peer Reviewed Medical Research Program

For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund for FY24. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) is sharing with you the FY24 funding mechanisms, award amounts, maximum direct costs and how to apply. FY24 […]

Read More… from FY24 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!

Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disease where the body’s natural defenses, like antibodies, attack the covering of the nerves, called myelin, and damage nerve function. While symptoms aren’t the same for everyone, CIDP can make your arms and legs feel weak and slow your movements. The purpose of the ARISE Study is […]

Read More… from Have you been diagnosed with CIDP? A clinical research study (ARISE) is now enrolling to evaluate an investigational medication.

PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM

The Foundation for Peripheral Neuropathy and the Department of Defense Peer-Reviewed Medical Research Program Co-Host March 8, 2023, Webinar About Award Pre-Applications CHICAGO, Feb. 28, 2023 /PRNewswire/ — For the third consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $370 million fund. In advance of pre-application deadlines, the Foundation for Peripheral Neuropathy (FPN) […]

Read More… from PERIPHERAL NEUROPATHY RESEARCHERS INVITED TO PRE-APPLY FOR RESEARCH GRANTS FROM DoD PEER REVIEWED MEDICAL RESEARCH PROGRAM

PNRR Study on Vitamin B6

Vitamin B6 toxicity is known to be a cause of peripheral neuropathy. There is debate regarding the threshold at which intake levels can cause neurological symptoms through vitamin B6. In a 2021 study from the Peripheral Neuropathy Research Registry (PNRR), funded by the Foundation for Peripheral Neuropathy, researchers asked if elevated plasma vitamin B6 levels […]

Read More… from PNRR Study on Vitamin B6

Research Study Back on Track!

Following over a year’s delay due to the COVID-19 pandemic, the IMAGiNe Study is finally back on track! The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) is a research program that aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to […]

Read More… from Research Study Back on Track!

FPN Welcomes the University of Michigan and Dr. Amro Stino

The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the […]

Read More… from FPN Welcomes the University of Michigan and Dr. Amro Stino

Gene Therapy Blocks Peripheral Nerve Damage in Mice

In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the […]

Read More… from Gene Therapy Blocks Peripheral Nerve Damage in Mice

IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.

The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN […]

Read More… from IMAGiNe Study on anti-MAG IgM paraprotein-associated peripheral neuropathy expanding in the U.S.

Long-Time Course of Idiopathic Small Fiber Neuropathy

Small study offers hope to patients with small fiber neuropathy Many patients diagnosed with small fiber neuropathy, one of the many forms of peripheral neuropathy, ask their physicians about their prognosis. Physicians are usually not sure how to answer, since there is not a lot of research to back whether the condition will improve or […]

Read More… from Long-Time Course of Idiopathic Small Fiber Neuropathy

Dr. Sandra Rieger’s Research Could Lead to Advances in Prevention of Peripheral Neuropathy

Sandra Rieger

What do zebrafish have to do with peripheral neuropathy research? In September 2017, we reported that Dr. Sandra Rieger had received a National Institutes of Health (NIH) research grant to continue her study of nerve regeneration and peripheral neuropathy. (See MDI Biological Laboratory Scientist Receives Grant to Study Peripheral Neuropathy.) In this study, she noticed […]

Read More… from Dr. Sandra Rieger’s Research Could Lead to Advances in Prevention of Peripheral Neuropathy